Report Summary
Eternity Insights has published a new study on Global Ophthalmic Therapeutics/Drug Market focusing on key segments as by Type (Antiallergy, Anti-VEGF agents, Anti-inflammatory, Antiglaucoma, Others), by Application (Dry Eye, Allergies, Glaucoma, Inflammation/Infection, Retinal Disorders, Uveitis, Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Ophthalmic Therapeutics/Drug Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Ophthalmic Therapeutics/Drug Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Ophthalmic Therapeutics/Drug Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Ophthalmic Therapeutics/Drug Market Segmentation:
Ophthalmic Therapeutics/Drug Market, By Type
- Antiallergy
- Anti-VEGF agents
- Anti-inflammatory
- Antiglaucoma
- Others
Ophthalmic Therapeutics/Drug Market, By Application
- Dry Eye
- Allergies
- Glaucoma
- Inflammation/Infection
- Retinal Disorders
- Uveitis
- Others
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Ophthalmic Therapeutics/Drug market in terms of demand generation. The Ophthalmic Therapeutics/Drug market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Ophthalmic Therapeutics/Drug market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Ophthalmic Therapeutics/Drug Market Taxonomy:
To learn more about this report
Global Ophthalmic Therapeutics/Drug Market Competitive Landscape
The global Ophthalmic Therapeutics/Drug market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Novartis AG
- Allergan
- Santen Pharmaceutical Co.
- Ltd.
- Pfizer Inc.
- Merck & Co.
- Inc.
- Genentech
- Inc.
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Antiallergy, Anti-VEGF agents, Anti-inflammatory, Antiglaucoma, Others |
| By Application Outlook |
Dry Eye, Allergies, Glaucoma, Inflammation/Infection, Retinal Disorders, Uveitis, Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Novartis AG, Allergan, Santen Pharmaceutical Co., Ltd., Pfizer Inc., Merck & Co., Inc., Genentech, Inc. |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Report Overview
1.1 Definition
1.2 Manufacturers and Regions Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.4 Application Overview
1.5 Industrial Chain
1.5.1 Ophthalmic Therapeutics/Drug Overall Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
1.5.4 Economic/Political Environment
2 Global Ophthalmic Therapeutics/Drug Market Assesment by Types
2.1 Overall Market Performance
2.1.1 Product Type Market Performance (Volume)
2.1.2 Product Type Market Performance (Value)
2.2 China Ophthalmic Therapeutics/Drug Market Performance
2.3 USA Ophthalmic Therapeutics/Drug Market Performance
2.4 Europe Ophthalmic Therapeutics/Drug Market Performance
2.5 Japan Ophthalmic Therapeutics/Drug Market Performance
2.6 Korea Ophthalmic Therapeutics/Drug Market Performance
2.7 India Ophthalmic Therapeutics/Drug Market Performance
2.8 Southeast Asia Ophthalmic Therapeutics/Drug Market Performance
2.9 South America Ophthalmic Therapeutics/Drug Market Performance
3 Global Ophthalmic Therapeutics/Drug Market Assesment by Application
3.1 Overall Market Performance (Volume)
3.2 China Ophthalmic Therapeutics/Drug Market Performance (Volume)
3.3 USA Ophthalmic Therapeutics/Drug Market Performance (Volume)
3.4 Europe Ophthalmic Therapeutics/Drug Market Performance (Volume)
3.5 Japan Ophthalmic Therapeutics/Drug Market Performance (Volume)
3.6 Korea Ophthalmic Therapeutics/Drug Market Performance (Volume)
3.7 India Ophthalmic Therapeutics/Drug Market Performance (Volume)
3.8 Southeast Asia Ophthalmic Therapeutics/Drug Market Performance (Volume)
3.9 South America Ophthalmic Therapeutics/Drug Market Performance (Volume)
4 Competitive Analysis
4.1 Novartis AG
4.1.1 Novartis AG Profiles
4.1.2 Novartis AG Product Information
4.1.3 Novartis AG Ophthalmic Therapeutics/Drug Production, Revenue, Price and Gross Margin
4.1.4 Novartis AG Ophthalmic Therapeutics/Drug Business Performance
4.1.5 SWOT Analysis
4.2 Allergan
4.2.1 Allergan Profiles
4.2.2 Allergan Product Information
4.2.3 Allergan Ophthalmic Therapeutics/Drug Production, Revenue, Price and Gross Margin
4.2.4 Allergan Ophthalmic Therapeutics/Drug Business Performance
4.2.5 SWOT Analysis
4.3 Santen Pharmaceutical Co., Ltd.
4.3.1 Santen Pharmaceutical Co., Ltd. Profiles
4.3.2 Santen Pharmaceutical Co., Ltd. Product Information
4.3.3 Santen Pharmaceutical Co., Ltd. Ophthalmic Therapeutics/Drug Production, Revenue, Price and Gross Margin
4.3.4 Santen Pharmaceutical Co., Ltd. Ophthalmic Therapeutics/Drug Business Performance
4.3.5 SWOT Analysis
4.4 Pfizer Inc.
4.4.1 Pfizer Inc. Profiles
4.4.2 Pfizer Inc. Product Information
4.4.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Production, Revenue, Price and Gross Margin
4.4.4 Pfizer Inc. Ophthalmic Therapeutics/Drug Business Performance
4.4.5 SWOT Analysis
4.5 Merck & Co., Inc.
4.5.1 Merck & Co., Inc. Profiles
4.5.2 Merck & Co., Inc. Product Information
4.5.3 Merck & Co., Inc. Ophthalmic Therapeutics/Drug Production, Revenue, Price and Gross Margin
4.5.4 Merck & Co., Inc. Ophthalmic Therapeutics/Drug Business Performance
4.5.5 SWOT Analysis
4.6 Genentech, Inc.
4.6.1 Genentech, Inc. Profiles
4.6.2 Genentech, Inc. Product Information
4.6.3 Genentech, Inc. Ophthalmic Therapeutics/Drug Production, Revenue, Price and Gross Margin
4.6.4 Genentech, Inc. Ophthalmic Therapeutics/Drug Business Performance
4.6.5 SWOT Analysis
5 Competitive Landscape
5.1 Global Ophthalmic Therapeutics/Drug Production (K Units) and Market Share by Manufacturers (2014-2020)
5.2 Global Ophthalmic Therapeutics/Drug Revenue (M USD) and Market Share by Manufacturers (2014-2020)
5.3 Global Ophthalmic Therapeutics/Drug Price (USD/Unit) of Manufacturers (2014-2020)
5.4 Global Ophthalmic Therapeutics/Drug Gross Margin of Manufacturers (2014-2020)
5.5 Market Concentration
6 Global Ophthalmic Therapeutics/Drug Market Assessment by Regions
6.1 Global Ophthalmic Therapeutics/Drug Production (K Units) and Market Share by Regions (2014-2020)
6.2 Global Ophthalmic Therapeutics/Drug Revenue (M USD) and Market Share by Regions (2014-2020)
6.3 Global Ophthalmic Therapeutics/Drug Price (USD/Unit) by Regions (2014-2020)
6.4 Global Ophthalmic Therapeutics/Drug Gross Margin by Regions (2014-2020)
7 Ophthalmic Therapeutics/Drug Regional Analysis
7.1 China Ophthalmic Therapeutics/Drug Production, Revenue and Growth Rate (2014-2020)
7.2 USA Ophthalmic Therapeutics/Drug Production, Revenue and Growth Rate (2014-2020)
7.3 Europe Ophthalmic Therapeutics/Drug Production, Revenue and Growth Rate (2014-2020)
7.4 Japan Ophthalmic Therapeutics/Drug Production, Revenue and Growth Rate (2014-2020)
7.5 Korea Ophthalmic Therapeutics/Drug Production, Revenue and Growth Rate (2014-2020)
7.6 India Ophthalmic Therapeutics/Drug Production, Revenue and Growth Rate (2014-2020)
7.7 Southeast Asia Ophthalmic Therapeutics/Drug Production, Revenue and Growth Rate (2014-2020)
7.8 South America Ophthalmic Therapeutics/Drug Production, Revenue and Growth Rate (2014-2020)
8 Global Ophthalmic Therapeutics/Drug Consumption Assessment
8.1 Global Ophthalmic Therapeutics/Drug Consumption and Market Share by Regions (2014-2020)
8.2 Global Ophthalmic Therapeutics/Drug Consumption Value and Market Share by Regions (2014-2020)
8.3 Global Ophthalmic Therapeutics/Drug Average Price (USD/Unit) by Regions (2014-2020)
9 Global Ophthalmic Therapeutics/Drug Sales Assessment by Regions
9.1 Global Ophthalmic Therapeutics/Drug Sales and Sales Value (2014-2020)
9.2 China Ophthalmic Therapeutics/Drug Sales and Sales Value (2014-2020)
9.3 USA Ophthalmic Therapeutics/Drug Sales and Sales Value (2014-2020)
9.4 Europe Ophthalmic Therapeutics/Drug Sales and Sales Value (2014-2020)
9.5 Japan Ophthalmic Therapeutics/Drug Sales and Sales Value (2014-2020)
9.6 Korea Ophthalmic Therapeutics/Drug Sales and Sales Value (2014-2020)
9.7 India Ophthalmic Therapeutics/Drug Sales and Sales Value (2014-2020)
9.8 Southeast Asia Ophthalmic Therapeutics/Drug Sales and Sales Value (2014-2020)
9.9 South America Ophthalmic Therapeutics/Drug Sales and Sales Value (2014-2020)
10 Technology and Cost
10.1 Technology
10.2 Cost
11 Channel Analysis
11.1 Market Channel
11.2 Distributors
12 Market Forecast 2020-2026
12.1 Production and Revenue Forecast 2020-2026
12.1.1 Global Ophthalmic Therapeutics/Drug Production and Revenue by Regions 2020-2026
12.1.2 China Ophthalmic Therapeutics/Drug Production, Revenue and Growth Rate 2020-2026
12.1.3 USA Ophthalmic Therapeutics/Drug Production, Revenue and Growth Rate 2020-2026
12.1.4 Europe Ophthalmic Therapeutics/Drug Production, Revenue and Growth Rate 2020-2026
12.1.5 Japan Ophthalmic Therapeutics/Drug Production, Revenue and Growth Rate 2020-2026
12.1.6 Korea Ophthalmic Therapeutics/Drug Production, Revenue and Growth Rate 2020-2026
12.1.7 India Ophthalmic Therapeutics/Drug Production, Revenue and Growth Rate 2020-2026
12.1.8 Southeast Asia Ophthalmic Therapeutics/Drug Production, Revenue and Growth Rate 2020-2026
12.1.9 South America Ophthalmic Therapeutics/Drug Production, Revenue and Growth Rate 2020-2026
12.2 Sales and Sales Value Forecast 2020-2026
12.2.1 Global Ophthalmic Therapeutics/Drug Consumption and Consumption Calue by Regions 2020-2026
12.2.2 Global Ophthalmic Therapeutics/Drug Sales and Sales Value Forecast 2020-2026
12.2.3 China Ophthalmic Therapeutics/Drug Sales, Sales Value and Growth Rate 2020-2026
12.2.4 USA Ophthalmic Therapeutics/Drug Sales and Sales Value Forecast 2020-2026
12.2.5 Europe Ophthalmic Therapeutics/Drug Sales and Sales Value Forecast 2020-2026
12.2.6 Japan Ophthalmic Therapeutics/Drug Sales and Sales Value Forecast 2020-2026
12.2.7 Korea Ophthalmic Therapeutics/Drug Sales and Sales Value Forecast 2020-2026
12.2.8 India Ophthalmic Therapeutics/Drug Sales and Sales Value Forecast 2020-2026
12.2.9 Southeast Asia Ophthalmic Therapeutics/Drug Sales and Sales Value Forecast 2020-2026
12.2.10 South America Ophthalmic Therapeutics/Drug Sales and Sales Value Forecast 2020-2026
12.3 Global Ophthalmic Therapeutics/Drug Production and Revenue Forecast by Type 2020-2026
12.3.1 Overall Market Performance
12.3.2 Antiallergy
12.3.3 Anti-VEGF agents
12.3.4 Anti-inflammatory
12.3.5 Antiglaucoma
12.3.6 Others
12.4 Global Ophthalmic Therapeutics/Drug Sales Forecast by Application 2020-2026
12.4.1 Overall Market Performance
12.4.2 Dry Eye
12.4.3 Allergies
12.4.4 Glaucoma
12.4.5 Inflammation/Infection
12.4.6 Retinal Disorders
12.4.7 Uveitis
12.4.8 Others
12.5 Global Ophthalmic Therapeutics/Drug Price and Gross Margin Forecast
13.5.1 Global Ophthalmic Therapeutics/Drug Averages Price Development Trend Forecast 2020-2026
13.5.2 Global Ophthalmic Therapeutics/Drug Gross Margin Development Trend Forecast 2020-2026
13 Conclusion
